Brolucizumab For The Treatment Of Visual Impairment Due To Diabetic Macular Edema: 52-Week Results From The Kite And Kestrel Studies

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE(2021)

引用 4|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要